Isnes, Belgium (September 14, 2012) – iSTAR Medical SA announced today that its STARflo PLUS™ project was awarded a €3,6 million collaborative research grant from Belgium’s Région Wallonne government in coordination with the region’s health competitiveness cluster BioWin.
iSTAR recruited fellow Wallonia-based partners Université catholique de Louvain (UCL), Université de Liège (ULg), and Neurotech SA to form a world-class consortium in the fields of biomaterials, bioengineering, microelectronics, biosensors, implant systems integration, and glaucoma disease management to help research and develop STARflo PLUS.
STARflo PLUS aims to be a breakthrough medical device implant system for glaucoma patients by combining the latest advances in biomaterials, biosensors, and telemedicine technologies. “Our consortium partners, and the greater glaucoma community, appreciate this significant support and validation from the Région Wallonne, BioWin, and their respective scientific juries,” stated Michel Alvarez, CEO of iSTAR. He added, “We are excited to advance this promising disease management solution for the millions of people suffering from glaucoma and at risk of blindness.”
Our consortium partners, and the greater glaucoma community, appreciate this significant support and validation from the Région Wallonne, BioWin, and their respective scientific juries.
, stated Michel Alvarez, CEO of iSTAR.
We are excited to advance this promising disease management solution for the millions of people suffering from glaucoma and at risk of blindness.
, he added.
EN
